Clindamycin Phosphate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Sagent Pharmaceuticals with status Current. The shortage was first posted on Mar 21, 2023. Reported reason: Discontinuation of the manufacture of the drug
Shortage details
- Status
- Current
- Company
- Sagent Pharmaceuticals
- Package NDC
- 25021-115-06
- Dosage Form
- Injection
- Presentation
- Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)
- Initial Posting
- Mar 21, 2023
Reason
Discontinuation of the manufacture of the drug